Long Term Supply Agreement - Panacea Biotec Ltd

Code BSE: 531349 NSE:

Panacea Biotec Limited has received a Letter of Award from UNICEF for a Long-Term Agreement for supply of bivalent oral polio vaccine (bOPV) to UNICEF starting from 1 st April 2026 to 31st March 2030. The total award to the Company is for supply of bOPV in 10 and 20 vial presentation worth US$ 35.65 million (~Rs.315 Crore) for a period of Q2 CY2026 and CY2027.